5 Wearable Medical Device Stocks to Monitor: WHSI, AUGX, NURO, MASI, IRTC

Wearable technology such as AI, Machine Learning, Internet of Things, cloud computing, Big Data and data analytics, are being adopted by the healthcare industry at a rapid rate. Research and Markets report, shipment volume of smart wearables globally is projected to reach 776.23 million units by 2026, registering a CAGR of 19.48% during the period of 2021-2026.

An increased emphasis on health and wellness monitoring is spurring growth in the wearable market.

There are several companies capitalizing on this trend.  Here are a few investors should research today.

Wearable Health Solutions (OTCMKTS:WHSI)  is a manufacturer of next-generation, advanced technology personal medical alarms and safety alert devices.  WHSI’s technology can provide a leading edge for the Company in our current cutting-edge technology-driven markets.

●          Unique Opportunity

Only Publicly Traded Small-Cap Stock in the $7.4 Billion PERS Market

●          Major Marketing Campaign Kickoff Imminent

WHSI is launching a worldwide marketing campaign to expand its international network of distributors. Production is underway for the company’s spots on the weekly ‘Worldwide Business With kathy ireland®” show.

Ireland’s Company Reaches Over 200+ Million Households broadcast on FOX Business Network, Bloomberg International Television and video streams on all major social media platforms.

●          iMax 4G Release

WHSI’s iHelp MAX™ 4G device is reportedly launching this year.  The device will do more than transmit an emergency alarm for the user. It will also send medical personnel vital signs, such as heart rate.  

This next-generation release would be huge for WHSI stock.

●          WHSI Up Listing

WHSI’s Mark Cayle recently commented after releasing its Form 10, “Once our Form 10 Registration Statement is effective, we will consider an up listing to a broader stock exchange which could expand our exposure to institutional investors, money managers, family office funds, broker dealers, and other investors which is an important milestone in our corporate progression,” he concluded

An uplisting would be a major catalytic event.

NeuroMatrix (NASDAQ:NURO) – While it is true that there has not been any news about NeuroMatrix Inc for quite a while, it may still be a company worth following. The last time the company was in the news was back on February 25 this year when it made an announcement with regards to its Quell wearable neuromodulation technology.

The company announced that the technology was going to be evaluated on individuals suffering from fibromyalgia-like syndrome following suffering from acute symptoms of COVID 19. At this point, investors could consider keeping an eye out for further information regarding the same in the future.

Augmedix Inc (NASDAQ:AUGX) announced that the company will be participating in the upcoming Lytham Partners Investors Conference, which will take place virtually from April 4 to April 7, 2022.

The company provides automated medical documentation and data services to large healthcare systems and physician practices, supporting medical offices, clinics, hospitals, emergency departments, and telemedicine nationwide.

Masimo Corporation (NASDAQ:MASI) – Back on March 30 Masimo Corporation had come into focus among investors after it announced its preliminary financial results for the first fiscal quarter that had ended on April 2, 2022.

The company announced that it expected its revenues for the first fiscal quarter of 2022 to be in the range between $285 million and $315 million. Supply chain issues had forced the company to lower its expectations with regards to the projected revenues. However, at the same time, it ought to be noted that the Masimo Corporation maintained its revenue projection for the full year 2022.

iRhythm Technologies Inc (NASDAQ:IRTC) – Major digital healthcare solutions firm iRhythm Technologies Inc was one of the companies that came into focus this week. Back on April 3 the company had announced the results of a total of three clinical care studies at a major industry event.

The presentation was done by the comapny at The American College of Cardiology’s 71st Annual Scientific Session & Expo. It was a major event for the company and one that could propel iRhythm Technologies to new heights in the coming months. It remains to be seen if the iRhythm Technologies stock makes a strong move in the coming days or not.